Benitec Biopharma Inc.
BNTC
$13.59
-$0.305-2.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.22% | 15.03% | -1.27% | 2.68% | -25.63% |
| Total Depreciation and Amortization | 1.25% | 10.98% | 8.33% | -3.23% | -21.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 90.43% | 378.02% | 260.32% | 156.00% | 308.89% |
| Change in Net Operating Assets | -148.13% | -104.40% | 147.75% | -1,185.50% | 357.46% |
| Cash from Operations | -43.58% | -0.20% | 19.58% | -53.09% | 8.18% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 45,730.77% | -29.88% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45,725.64% | -22.44% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 273.62% | -306.67% | -123.81% | 167.44% | -6.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 290.20% | -27.41% | 1,002.40% | -56.35% | 8.46% |